ask="3.350"
ask_size="100"
average_daily_volume="237513"
bid="3.100"
bid_size="2000"
book_value="3.405"
change="+0.166"
change_from_200_day_moving_average="0.037"
change_from_50_day_moving_average="0.316"
change_from_52_week_high="-4.114"
change_From_52_week_low="1.426"
change_in_percent="+5.338%"
close="3.276"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-7.487"
ebitda="-7.62M"
eps_estimate_current_year="-1.180"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-1.270"
ex_dividend_date="N/A"
float_shares="2302000"
high="3.350"
high_52_weeks="7.390"
last_trade_date="3/16/2017"
last_trade_price="3.276"
last_trade_size="400"
last_trade_time="3:59pm"
low="3.010"
low_52_weeks="1.850"
market_capitalization="32.39M"
moving_average_200_day="3.239"
moving_average_50_day="2.960"
name="Cesca Therapeutics Inc."
notes="N/A"
one_year_target_price="2.000"
open="3.010"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+1.131%"
percent_change_from_50_day_moving_average="+10.676%"
percent_change_from_52_week_high="-55.670%"
percent_change_from_52_week_low="+77.072%"
previous_close="3.110"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.913"
price_per_sales="2.263"
revenue="13.58M"
shares_outstanding="9886000"
short_ratio="11.520"
stock_exchange="NCM"
symbol="KOOL"
volume="303144"
weeks_range_52="1.850 - 7.390"
